Raynaud's phenomenon in older adults: diagnostic considerations and management
- PMID: 10503811
- DOI: 10.2165/00002512-199915030-00002
Raynaud's phenomenon in older adults: diagnostic considerations and management
Erratum in
- Drugs Aging 2000 Feb;16(2):121
Abstract
Raynaud's phenomenon (RP) is characterised by sensitivity to cold temperatures associated with either biphasic or uniphasic change in colour of the digits. Since few studies are available which include older adults, the prevalence of RP in the older adult population is estimated from surveys or studies of the general population. The causes of RP in older adults may differ significantly from those in young adults and, therefore, so would the evaluation of RP. Because of comorbitis that accompany advancing age, the management of RP in older adult patients must take into consideration toxicity and adverse reactions that may develop, especially in the frail individual. Although nonpharmacological therapy is preferable, slow-release calcium antagonists provide a relatively well tolerated and effective treatment for moderate to severe RP in older adult patients. Aggressive treatment including hospitalisation is appropriate for older adult patients during periods of critical digital ischaemia associated with RP.
Similar articles
-
Raynaud's phenomenon-an update on diagnosis, classification and management.Clin Rheumatol. 2019 Dec;38(12):3317-3330. doi: 10.1007/s10067-019-04745-5. Epub 2019 Aug 16. Clin Rheumatol. 2019. PMID: 31420815 Review.
-
Raynaud's phenomenon and digital ischaemia--pharmacologic approach and alternative treatment options.Vasa. 2016;45(3):201-12. doi: 10.1024/0301-1526/a000526. Vasa. 2016. PMID: 27129065 Review.
-
ESVM guidelines - the diagnosis and management of Raynaud's phenomenon.Vasa. 2017 Oct;46(6):413-423. doi: 10.1024/0301-1526/a000661. Epub 2017 Sep 12. Vasa. 2017. PMID: 28895508 Review.
-
Office evaluation and treatment of Raynaud's phenomenon.Cleve Clin J Med. 1995 Jan-Feb;62(1):51-61. doi: 10.3949/ccjm.62.1.51. Cleve Clin J Med. 1995. PMID: 7859402 Review.
-
Prevalence of Raynaud's phenomenon in healthy Turkish medical students and hospital personnel.Rheumatol Int. 2008 Dec;29(2):185-8. doi: 10.1007/s00296-008-0666-9. Epub 2008 Aug 6. Rheumatol Int. 2008. PMID: 18682952
Cited by
-
Lymphoplasmacytic Lymphoma Presenting as Severe Secondary Raynaud's Phenomenon.Cureus. 2024 Nov 21;16(11):e74144. doi: 10.7759/cureus.74144. eCollection 2024 Nov. Cureus. 2024. PMID: 39712791 Free PMC article.
-
Raynaud's syndrome: comparison of late and early onset forms using hand perfusion scintigraphy.Rheumatol Int. 2006 Sep;26(11):1014-8. doi: 10.1007/s00296-006-0121-8. Epub 2006 Apr 8. Rheumatol Int. 2006. PMID: 16604347 Clinical Trial.
-
New lines in therapy of Raynaud's phenomenon.Rheumatol Int. 2009 Feb;29(4):355-63. doi: 10.1007/s00296-008-0792-4. Epub 2008 Nov 27. Rheumatol Int. 2009. PMID: 19037602 Review.
-
The role of capillaroscopy in differentiation of primary and secondary Raynaud's phenomenon in rheumatic diseases: a review of the literature and two case reports.Rheumatol Int. 2009 Sep;29(11):1263-71. doi: 10.1007/s00296-009-1019-z. Epub 2009 Jun 23. Rheumatol Int. 2009. PMID: 19547979 Review.
-
A Review of Raynaud's Disease.Mo Med. 2016 Mar-Apr;113(2):123-6. Mo Med. 2016. PMID: 27311222 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical